Raymond F. Schinazi's most recent trade in Precision Biosciences Inc was a trade of 156,951 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 10, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Precision Biosciences Inc | Raymond F. Schinazi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2022 | 156,951 | 156,951 | - | - | Stock Option (Right to Buy) | |
| Precision Biosciences Inc | Raymond F. Schinazi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2021 | 32,800 | 32,800 | - | - | Stock Option (Right to Buy) | |
| Cocrystal Pharma Inc | Raymond F. Schinazi | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.95 per share. | 04 May 2021 | 575,000 | 7,674,960 (16%) | 1% | 3.0 | 1,696,250 | Common Stock |